Pursuant to Government Resolution 1587, which instituted a medicalization model for the cannabis plant, and as a result of the Israeli Ministry of Health reform and the establishment of the Medical Cannabis Unit, Dor established a Medical Cannabis Division with the objective of providing professional, high-quality solutions to Israeli medical cannabis companies that focus on shortening the time to market and on strict compliance with the new regulations. Dor’s customers include medical cannabis cultivation and propagation farms (indoor facilities and hothouses), medical cannabis production plants (oil extracts, cigarettes, packages of dried flowers, suppositories and a variety of additional forms of administration), medical cannabis storage and distribution stores, licensed medical cannabis pharmacies, importers of finished goods containing medical cannabis under EU-GMP, importers of food supplements, perfumes and foods containing medical cannabis (CBD, THC and more), manufacturers of medical devices that integrate medical cannabis, technology companies, entrepreneurs and start-up companies.
Dor Pharmaceutical Services Ltd. is a regulatory pioneer in the medical cannabis market in Israel. Dor’s expertise in the medical cannabis sector was demonstrated by its successful accompaniment of IMC-GMP audits under the new regulations pursuant to the directives of the Medical Cannabis Unit of the Pharmacy Department, the Ministry of Health. Over the years, Dor has instituted work processes and cooperative efforts with regulatory authorities in Israel and abroad in order to ensure that its customers receive the highest-quality service as quickly as possible.
Dor is a member of the Novolog Group. A number of medical cannabis companies operate within the Group, which supply logistics and distribution services to pharmacies, distribution to customers homes, logistics services to clinical research studies on medical cannabis and more.
Dor provides one-stop shopping services in the medical cannabis market, including: the establishment of facilities, validations, pharmacy services, product registrations, packaging materials and printing, qualifications, quality assurance and regulatory affairs, monitoring of adverse effects and clinical research.
Registrations of medical cannabis products
Packaging materials for medical cannabis products
Regulatory assistance to private/white label medical cannabis companies
Dor Pharmaceutical Services has gained the trust of more than 150 customers since its inception in 2011. Its customers include some of the largest and best-known pharmaceutical and medical device manufacturers in the world, both manufacturers of original (innovative) products and manufacturers of generic products. With the help of Dor's comprehensive solutions, many companies have achieved fast and quality results, including start-ups, biotech companies, small and medium-sized companies.